MENU
RIGL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Rigel Pharmaceuticals (RIGL) Ownership - Who owns Rigel Pharmaceuticals?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
611 Gateway Boulevard
Phone
+1 650 624-1100
Employees
147
Web
https://www.rigel.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
325M
P/E Ratio
68.33
Total Cash
61.11M
Projected Growth
N/A
Total Debt
60.23M
Revenue
157.47M
Risk (Beta)
0.57
Dividend Yield
N/A
Total Cash/Share
3.47
Total Debt/Equity
N/A
Revenue/Share
8.97 USD as % of share price
Fundamentals
RIGL
Capitalization
325M
P/E Ratio
68.33
Risk (Beta)
0.57
Dividend Yield
N/A
Total Cash
61.1M
Total Cash/Share
3.47
Total Debt
60.2M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
8.97%
Revenue
157M
ROE
N/A
Book Value
-14.64M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
0.27
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
17K
Current Ratio
1.96
Current Revenue Per Employee
376238.10
Dividends Per Share - Security
N/A
EBITDA
13.7M
Float
N/A
Float - Current
N/A
Gross Income Margin
85.49
Revenue To Assets
3.05
Shares Held By Institutions
196M
Shares Outstanding - Current
17.6M
Total Liabilities
154M
Total Volume MTD
N/A
Value
-1
Gain YTD
27.241
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical-stage drug development company that discovers and develops novel, small-molecule drugs
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
611 Gateway Boulevard
Phone
+1 650 624-1100
Employees
147
Web
https://www.rigel.com